Ethics & Compliance Intern

Istanbul, Istanbul, Turkiye

Auto‑apply with AI Apply

Not SpecifiedCompensation

Entry Level & New GradExperience Level

InternshipJob Type

UnknownVisa

PharmaceuticalIndustries

Requirements

The ideal candidate is a 3rd or 4th year university student with good command of English, both verbal and written, and eager to learn through experience. They must also be able to work at least 3 days a week, and Lilly is dedicated to providing accommodations for individuals with disabilities.

Responsibilities

The Ethics and Compliance Intern will support the development and delivery of Ethics and Compliance trainings and communications, assist the L&D team with training processes, support the organization of E&C champion meetings and programs, and aid in the coordination and implementation of policies and procedures, including the localization of global procedures.

Skills

Ethics

Compliance

Training Development

Policy Coordination

Localization

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free